BRAMPTON, Ontario – July 15, 2021 – Medtronic Canada ULC, a subsidiary of Medtronic plc (NYSE:MDT) – the global leader in medical technology – has received a licence from Health Canada for...
BRAMPTON, Ontario – July 15, 2021 – Medtronic Canada ULC, a subsidiary of Medtronic plc (NYSE:MDT) – the global leader in medical technology – has received a licence from Health Canada for Rist™ 079 Radial Access Guide Catheter and Rist™ Radial Access Selective Catheter, adding the first-of-its-kind radial access catheter system to the Medtronic neurovascular portfolio, enhancing the ability to serve patients requiring interventional neurovascular therapy.
The Rist 079 Radial Access Guide Catheter is indicated for the introduction of interventional devices into the peripheral, coronary, and neurovasculature. It is the first catheter designed and licensed specifically to navigate the radial artery pathway in the wrist for neurointerventions. When compared to the traditional femoral approach, transradial access (TRA) has been associated with significantly reduced access site complications when accessing the neurovasculature.1
“Cardiac interventions have been treated through TRA techniques for many years due to lower access complication rates,” said Dr. Sachin Pandey, radiologist from London Health Sciences Centre. “That’s why as an interventional neuroradiologist, I am pleased to finally have a device dedicated to this type of approach in the neurovascular field.”